Citigroup
DMK

Citigroup’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Citigroup’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed – – 6797
2022
Q1 		$0 Buy
+4
New +$172 ﹤0.01% 6715
2016
Q2 		– Sell
-3
Closed -$1K – 7525
2016
Q1 		$1K Sell
3
-11
-79% -$3.93K ﹤0.01% 7356
2015
Q4 		$5K Sell
14
-15
-52% -$4.7K ﹤0.01% 7072
2015
Q3 		$8K Sell
29
-14
-33% -$3.9K ﹤0.01% 6565
2015
Q2 		$13K Sell
43
-3
-7% -$906 ﹤0.01% 6343
2015
Q1 		$13K Buy
46
+16
+53% +$6.91K ﹤0.01% 6347
2014
Q4 		$12K Buy
+30
New +$9.53K ﹤0.01% 6427
2014
Q2 		– Sell
-6
Closed -$3K – 7362
2014
Q1 		$3K Buy
+6
New +$2.72K ﹤0.01% 6729

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Citigroup's DMK Position: Q2 2022 in Review

Citigroup sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2022, closing a stake of 4 shares.

Citigroup first reported a position in DMK in Q1 2014 and held it in 8 quarters. The position peaked at $13K in Q2 2015. 45 funds tracked by Wall St. Rank hold DMK as of Q2 2022.

  • Citigroup reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 4 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2022.
  • Citigroup first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 8 quarters.
  • Citigroup's DMK Pharmaceuticals Corporation Common Stock position peaked at $13K in Q2 2015.
  • 45 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.